Yongzhufang
The author Chen Jiayi, this article only represents the author’s own point of view.
Stepping into 2023, Lu Daopei Medical Group, which operates three hematology hospitals in China, has become the first company to submit a listing application to the Hong Kong Stock Exchange. Since the company was founded by Lu Daopei, an authoritative hematologist and expert in hematopoietic stem cell transplantation, its strong professional background has impressed the market.
Lu Daopei is an academician of the Chinese Academy of Engineering and has been engaged in clinical and experimental research on blood diseases since 1957. He has made great contributions to allogeneic bone marrow transplantation and traditional Chinese medicine treatment of acute myeloid leukemia…
